Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...

Merck & Co. Inc. closed 29.59% below its 52-week high of $134.63, which the company reached on June 25th.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Merck (MRK), known as MSD outside of the United States and Canada, today provided an update on the open-label arm of the... By Davit Kirakosyan Wells Fargo upgraded Amgen (NASDAQ:AMGN) and Eli ...

The general mood among these heavyweight investors is divided, with 63% leaning bullish and 36% bearish. Among these notable ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the April 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...

At Holdings Channel, we have reviewed the latest batch of the 27 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Merck & Co Inc (Symbol: MRK) was held by 15 of these ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a ...

Shares of Merck & Co. Inc. MRK advanced 1.34% to $90.58 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.59% to 5,861. ...